Consulting the patients: Avastin in the treatment of Wet AMD (Part II).
作者信息
Mohamed Ryian, Saunders David C, Mathews John P
机构信息
Betsi Cadwaladr University Health Board, Abergele Hospital, Abergele, UK.
出版信息
Eye (Lond). 2019 Jun;33(6):871-873. doi: 10.1038/s41433-019-0366-6. Epub 2019 Feb 13.
Abstract
摘要
相似文献
1
Consulting the patients: Avastin in the treatment of Wet AMD (Part II).咨询患者：阿瓦斯汀治疗湿性年龄相关性黄斑变性（第二部分）
Eye (Lond). 2019 Jun;33(6):871-873. doi: 10.1038/s41433-019-0366-6. Epub 2019 Feb 13.
2
Off-label use of bevacizumab for wet age-related macular degeneration in Europe.贝伐单抗在欧洲用于湿性年龄相关性黄斑变性的标签外使用。
Graefes Arch Clin Exp Ophthalmol. 2020 Mar;258(3):503-511. doi: 10.1007/s00417-019-04569-8. Epub 2019 Dec 30.
3
Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration.年龄相关性黄斑变性患者单剂量或重复剂量玻璃体内注射贝伐单抗后发生心肌梗死和中风的风险
Am J Ophthalmol. 2016 Mar;163:53-58. doi: 10.1016/j.ajo.2015.11.030. Epub 2015 Dec 15.
4
Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment.雷珠单抗和贝伐单抗交替双周玻璃体内注射治疗伴有色素上皮脱离的难治性新生血管性年龄相关性黄斑变性
Semin Ophthalmol. 2017;32(3):309-315. doi: 10.3109/08820538.2015.1072222. Epub 2015 Sep 4.
5
Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.玻璃体内注射抗血管内皮生长因子治疗湿性年龄相关性黄斑变性：一项系统评价与Meta分析
Drug Des Devel Ther. 2015 Sep 28;9:5397-405. doi: 10.2147/DDDT.S86269. eCollection 2015.
6
Time to ask patients about drugs for macular degeneration.
BMJ. 2017 Nov 28;359:j5426. doi: 10.1136/bmj.j5426.
7
8
Intravitreal Bevacizumab with or without Triamcinolone for Wet Age-related Macular Degeneration: Twelve-month Results of a Prospective, Randomized Investigation.玻璃体腔注射贝伐单抗联合或不联合曲安奈德治疗湿性年龄相关性黄斑变性：一项前瞻性随机研究的12个月结果
Middle East Afr J Ophthalmol. 2018 Jan-Mar;25(1):1-7. doi: 10.4103/meajo.MEAJO_292_16.
9
Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration.在新生血管性年龄相关性黄斑变性眼中玻璃体内注射贝伐单抗后，眼内压持续升高。
Graefes Arch Clin Exp Ophthalmol. 2012 Oct;250(10):1435-40. doi: 10.1007/s00417-012-1981-0. Epub 2012 Mar 21.
10
A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗、雷珠单抗或阿柏西普治疗新生血管性年龄相关性黄斑变性的疗效比较。
Int Ophthalmol. 2017 Oct;37(5):1205-1214. doi: 10.1007/s10792-016-0391-4. Epub 2016 Nov 8.
引用本文的文献
1
Response to "Comment on 'Consulting the consultants: Avastin in the treatment of wet AMD'".对《关于“咨询专家：阿瓦斯汀治疗湿性年龄相关性黄斑变性”的评论》的回应
Eye (Lond). 2019 Nov;33(11):1822. doi: 10.1038/s41433-019-0533-9. Epub 2019 Jul 31.
Zotero 插件